Myofilament response to Ca2+ and Na+/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 2, 2007, Pages

  Bupha Intr, Tepmanas ^b   Wattanapermpool, Jonggonnee ^b   Peña, James R ^a   Wolska, Beata M ^a   Solaro, R J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Estrogen; Heart; Proton exchanger; Sarcomeric proteins; Sodium

Indexed keywords

CALCIUM; HYDROGEN; SEX HORMONE; SODIUM; SODIUM PROTON EXCHANGE PROTEIN 1; ANTIARRHYTHMIC AGENT; CARIPORIDE; ESTROGEN; GUANIDINE DERIVATIVE; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN; SULFONE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL ISOLATION; CELL PROTECTION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART MUSCLE CELL; HYPERCAPNIA; MYOFILAMENT; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RESPIRATORY ACIDOSIS; SEX DIFFERENCE; SODIUM CALCIUM EXCHANGE; ANIMAL; CALCIUM SIGNALING; CELL SEPARATION; DRUG EFFECT; HEART CONTRACTION; IN VITRO STUDY; KINETICS; METABOLISM; MICROFILAMENT; MUSCLE CELL; PATHOPHYSIOLOGY; PH; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACIDOSIS, RESPIRATORY; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM; CALCIUM SIGNALING; CELL SEPARATION; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; GUANIDINES; HYDROGEN-ION CONCENTRATION; HYPERCAPNIA; KINETICS; MICROFILAMENTS; MUSCLE FIBERS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-CALCIUM EXCHANGER; SODIUM-HYDROGEN ANTIPORTER; SULFONES;

EID: 33846815376     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00376.2006     Document Type: Article

References (40)

1. 2+ and ischemia-reperfusion injury. Am J Physiol Cell Physiol 288: C57-C64, 2005.
2. 2+ protects murine myocardium against ischemia/reperfusion dysfunction. Am J Physiol Heart Circ Physiol 289: H2183-H2192, 2005.
3. Bupha-Intr T, Wattanapermpool J. Cardioprotective effects of exercise training on myofilament calcium activation in ovariectomized rats. J Appl Physiol 96: 1755-1760, 2004.
4. Bupha-Intr T, Wattanapermpool J. Regulatory role of ovarian sex hormones in the calcium uptake activity of cardiac sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol 291: H1101-H1108, 2006.
5. Cross HR, Murphy E, Steenbergen C. Ca(2) loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 283: H481-H489, 2002.
6. Day SM, Westfall MV, Fomicheva EV, Hoyer K, Yasuda S, La Cross NC, D'Alecy LG, Ingwall JS, Metzger JM. Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med 12: 181-189, 2006.
7. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79, 2003.
8. Godt RE, Lindley B. Influence of temperature upon contractile activation and isometric force production in mechanically skinned muscle fibers of the frog. J Gen Physiol 80: 279-297, 1982.
9. Gomes AV, Potter JD. Molecular and cellular aspects of troponin cardiomyopathies. Ann NY Acad Sci 1015: 214-224, 2004.
10. 2+ sensitivity of cardiomyopathic hamster hearts. Pflügers Arch 429: 539-545, 1995.
11. Karmazyn M. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury. From amiloride to cariporide. Ann NY Acad Sci 874: 326-334, 1999.
12. Kass D, Solaro RJ. Mechanisms and use of calcium-sensitizing agents. Circulation 113: 305-315, 2006.
13. Kuhn FE, Rackley CE. Coronary artery disease in women. Risk factors, evaluation, treatment, and prevention. Arch Intern Med 13: 2626-2636, 1993.
14. Layland J, Cave AC, Grieve DJ, Sparks E, Kentish JC, Warren C, Solaro RJ, Shah AM. Protection against endotoxaemia induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J 19: 1137-1139, 2005.
15. Lindenfeld J, Ghali JK, Krause-Steinrauf HJ, Khan S, Adams K, Goldman S, Peberdy MA, Yancy C, Thaneemit-Chen S, Larsen RL, Young J, Lowes B, Rosenberg YD, Investigators BEST. Hormone replacement therapy is associated with improved survival in women with advanced heart failure. J Am Coll Cardiol 42: 1238-1245, 2003.
16. Morimoto K, Kurahashi Y, Shintani-Ishida K, Kawamura N, Miyashita M, Uji Tan N M, Yoshida K. Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats. Am J Physiol Heart Circ Physiol 287: H1950-H1956, 2004.
17. 2+ exchange during ischemia and reperfusion beneficial or detrimental? Ann NY Acad Sci 976: 421-430, 2002.
18. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C, Force T, Mendelsohn ME, Karas RH. 17β-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 95: 692-629, 2004.
19. Pines A, Fisman EZ, Shemesh J, Levo Y, Ayalon D, Kellermann JJ, Motro M, Drory Y. Menopause-related changes in left ventricular function in healthy women. Cardiology 80: 413-416, 1992.
20. Reis SE, Holubkov R, Young JB, White BG, Cohn JN, Fledman AM. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies. J Am Coll Cardiol 36: 529-533, 2000.
21. Ren J, Hintz KK, Roughead ZK, Duan J, Colligan PB, Ren BH, Lee KJ, Zeng H. Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation. Am J Physiol Heart Circ Physiol 284: H1800-H1807, 2003.
22. Rice JJ, de Tombe PP. Approaches to modeling crossbridges and calcium-dependent activation in cardiac muscle. Prog Biophys Mol Biol 85: 179-195, 2004.
23. Schaible TF, Scheuer J. Comparison of heart function in male and female rats. Basic Res Cardiol 79: 402-412, 1984.
24. Schaible TF, Malhotra A, Ciambrone G, Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res 54: 38-49, 1984.
25. Solaro RJ. Modulation of cardiac myofilament activity by protein phosphorylation. Handbook of Physiology: The Cardiovascular System. Bethesda, MD: Am. Physiol. Soc., 2001, sect. 2, vol. 1, chapt. 7, 2001, p. 264-300.
26. Solaro RJ, Lee JA, Kentish JC, Allen DG. Effects of acidosis on ventricular muscle from adult and neonatal rats. Circ Res 63: 779-787, 1988.
27. Solaro RJ, Hasenfuss G. Control of cardiac function in health and disease by mechanisms at the level of the sarcomere. In: Molecular Mechanisms of Cardiac Hypertrophy and Failure, edited by Walsh RA. London: Taylor and Francis, 2005, p. 265-279.
28. 2+ exchanger. Circulation 104: 2102-2106, 2001.
29. Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304: 1269-1273, 2004.
30. Tytgat J. How to isolate cardiac myocytes. Cardiovasc Res 28: 280-283, 1994.
31. Urboniene D, Dias F, Peña JR, Walker LA, Solaro RJ, Wolska BM. Expression of slow skeletal troponin I in adult mouse heart helps to maintain the left ventricular systolic function during respiratory hypercapnia. Circ Res 97: 70-77, 2005.
32. Wattanapermpool J. Increase in calcium responsiveness of cardiac myofilament activation in ovariectomized rats. Life Sci 63: 955-964, 1998.
33. Wattanapermpool J, Reiser PJ. Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments. Am J Physiol Heart Circ Physiol 277: H467-H473, 1999.
34. Wattanapermpool J, Reiser PJ, Solaro RJ. Troponin I isoforms and differential effects of acidic pH on soleus and cardiac myofilaments. Am J Physiol Cell Physiol 268: C323-C330, 1995.
35. Wattanapermpool J, Riabroy T, Preawnim S. Estrogen suppement prevents the calcium hypersensitivity of cardiac myofilaments in ovariectomized rats. Life Sci 66: 533-543, 2000.
36. Wolff MR, Buck SH, Stoker SW, Greaser ML, Mantzer RM. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. J Clin Invest 98: 167-176, 1996.
37. + homeostasis in rat ventricular myocytes. J Mol Cell Cardiol 29: 2653-2663, 1997.
38. Wolska BM, Kitada Y, Palmiter KA, Westfall MA, Johnson MD, and Solaro RJ. CGP48506, a novel benzodiazocine derivative, increases contractility of ventricular myocytes and myofilaments by direct effects on the actin-myosin reaction. Am J Physiol Heart Circ Physiol 270: H24-H32, 1996.
39. Wolska BM, Vijayan K, Arteaga GM, Konhilas JP, Phillips RM, Kim R, Naya T, Leiden JM, Martin AF, de Tombe PP, Solaro RJ. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions. J Physiol 536: 863-870, 2001.
40. 2+. Am J Physiol Cell Physiol 271: C391-C397, 1996.